diabetes-mellitus

Documents about diabetes-mellitus

• First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050#181708ClinicalTrials.gov
• Personalized Glucose Optimization Through Nutritional Intervention#195502ClinicalTrials.gov
• Plasma proteome profiling identifies XPNPEP3 as a novel biomarker associated with metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus#120093Europe PMC
• Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)#18556ClinicalTrials.gov
• Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes#28552ClinicalTrials.gov
• DIABETES AWARENESS AND TREATMENT COMPLIANCE AMONG TYPE 2 DIABETIC PARENTS OF UDAYANA MEDICAL STUDENTS#15719DataCite
• DIABETES AWARENESS AND TREATMENT COMPLIANCE AMONG TYPE 2 DIABETIC PARENTS OF UDAYANA MEDICAL STUDENTS#15720DataCite
• Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes#123425ClinicalTrials.gov
• A Regulatory Requirement Non Interventional Study to Monitor Safety and Effectiveness of Trajenta Duo in Type 2 Diabetes Patients in Korea#126066ClinicalTrials.gov
• Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 Diabetes#127749ClinicalTrials.gov
• Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in Qatar#136180ClinicalTrials.gov
• Central Insulin Sensitivity in Individuals With Type 2 Diabetes (T2D) and at Risk for Developing T2D#146349ClinicalTrials.gov
• A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients#146379ClinicalTrials.gov
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin#154863ClinicalTrials.gov
• Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy#160268ClinicalTrials.gov
• Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin#160327ClinicalTrials.gov
• Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin#162417ClinicalTrials.gov
• Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy#180279ClinicalTrials.gov
• Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes#181731ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes#184794ClinicalTrials.gov
• The Efficacy of Glucerna SR in Chinese Drug-naïve Subjects With Type 2 Diabetes#201709ClinicalTrials.gov
• Asociación entre exposición laboral a diésel y diabetes mellitus tipo 2 en trabajadores pirquineros y mineros artesanales de la región de Atacama, Chile#188043Repositorio Académico de la Universidad de Chile
• Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes#160309ClinicalTrials.gov
• Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide#141166ClinicalTrials.gov
• Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs#158166ClinicalTrials.gov
• Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose#18535ClinicalTrials.gov
• Thermographic Camera Validation for Diabetic Foot Assessment (HIK-DM-2026)#28514ClinicalTrials.gov
• A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects#67786ClinicalTrials.gov
• Role of Fasted Exercise on Improving Cardiometabolic Health#126011ClinicalTrials.gov
• The Glycaemic Effect of Isomaltulose Consumption in Healthy Participants#127775ClinicalTrials.gov
• Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)#127844ClinicalTrials.gov
• Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)#136278ClinicalTrials.gov
• Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users#136284ClinicalTrials.gov
• Ghrelin and Diastolic Heart Function#148689ClinicalTrials.gov
• Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)#154892ClinicalTrials.gov
• Quality Initiative to Improve Glucose Control in Type 2 Diabetic Patients#158136ClinicalTrials.gov
• Renohemodynamic Effects of Combined empagliflOzin and LosARtan#160332ClinicalTrials.gov
• Autologous Adoptive T Regulatory Cell Transfer in Autoimmune Diseases.#171295ClinicalTrials.gov
• Vitamin D and HbA1c Levels in Diabetic Patients With CKD#172490ClinicalTrials.gov
• Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells#172504ClinicalTrials.gov
• Comparison of Coronary Xience V and the Cypher Select+ Stents in Diabetic Patients#180316ClinicalTrials.gov
• Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients#180356ClinicalTrials.gov
• Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients#181732ClinicalTrials.gov
• Comparison of Progressive Muscle Relaxation and Stretching Exercises in Diabetic Population#184765ClinicalTrials.gov
• Egg Effects on Atherogenic Dyslipidemias, Glucose Metabolism and Inflammation in Diabetic Subjects#201694ClinicalTrials.gov
• Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin#18569ClinicalTrials.gov
• Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease#18805ClinicalTrials.gov
• Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease#28553ClinicalTrials.gov
• A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)#28580ClinicalTrials.gov
• Patient Activation Through Community Empowerment/Engagement for Diabetes Management (PACE-D)#121251ClinicalTrials.gov